These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36622150)

  • 1. Protective Capacity of Monoclonal Antibodies against Acinetobacter baumannii K9 Capsular Polysaccharide.
    Karatovskaya A; Rudenko N; Zamyatina A; Zvonarev A; Oleinikov V; Shpirt A; Perepelov A; Knirel Y; Brovko F
    Microbiol Spectr; 2023 Feb; 11(1):e0414122. PubMed ID: 36622150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Response to Conjugates of Fragments of the Type K9 Capsular Polysaccharide of Acinetobacter baumannii with Carrier Proteins.
    Rudenko N; Karatovskaya A; Zamyatina A; Shepelyakovskaya A; Semushina S; Brovko F; Shpirt A; Torgov V; Kolotyrkina N; Zinin A; Kasimova A; Perepelov A; Shneider M; Knirel Y
    Microbiol Spectr; 2022 Oct; 10(5):e0167422. PubMed ID: 35980044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.
    Wang-Lin SX; Olson R; Beanan JM; MacDonald U; Balthasar JP; Russo TA
    Infect Immun; 2017 Dec; 85(12):. PubMed ID: 28947651
    [No Abstract]   [Full Text] [Related]  

  • 4. K2 Capsule Depolymerase Is Highly Stable, Is Refractory to Resistance, and Protects Larvae and Mice from Acinetobacter baumannii Sepsis.
    Oliveira H; Mendes A; Fraga AG; Ferreira A; Pimenta AI; Mil-Homens D; Fialho AM; Pedrosa J; Azeredo J
    Appl Environ Microbiol; 2019 Sep; 85(17):. PubMed ID: 31227554
    [No Abstract]   [Full Text] [Related]  

  • 5. Semi-Synthetic Glycoconjugate Vaccine Lead Against Acinetobacter baumannii 17978.
    Sianturi J; Priegue P; Hu J; Yin J; Seeberger PH
    Angew Chem Int Ed Engl; 2022 Oct; 61(41):e202209556. PubMed ID: 35950629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis.
    Nielsen TB; Pantapalangkoor P; Luna BM; Bruhn KW; Yan J; Dekitani K; Hsieh S; Yeshoua B; Pascual B; Vinogradov E; Hujer KM; Domitrovic TN; Bonomo RA; Russo TA; Lesczcyniecka M; Schneider T; Spellberg B
    J Infect Dis; 2017 Aug; 216(4):489-501. PubMed ID: 28931235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal Antibody Therapy against
    Nielsen TB; Yan J; Slarve M; Lu P; Li R; Ruiz J; Lee B; Burk E; Talyansky Y; Oelschlaeger P; Hurth K; Win W; Luna BM; Bonomo RA; Spellberg B
    Infect Immun; 2021 Sep; 89(10):e0016221. PubMed ID: 34310884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A medically relevant capsular polysaccharide in Acinetobacter baumannii is a potential vaccine candidate.
    Yang FL; Lou TC; Kuo SC; Wu WL; Chern J; Lee YT; Chen ST; Zou W; Lin NT; Wu SH
    Vaccine; 2017 Mar; 35(10):1440-1447. PubMed ID: 28190743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic effect of phages on extensively drug-resistant Acinetobacter baumannii-induced sepsis in mice].
    Deng LY; Yang ZC; Gong YL; Huang GT; Yin SP; Jiang B; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):523-8. PubMed ID: 27647067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The
    Kasimova AA; Sharar NS; Ambrose SJ; Knirel YA; Shneider MM; Timoshina OY; Popova AV; Perepelov AV; Dmitrenok AS; Hsu LY; Hall RM; Kenyon JJ
    Microbiol Spectr; 2023 Dec; 11(6):e0302523. PubMed ID: 37975684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation the reactivity of a peptide-based monoclonal antibody derived from OmpA with drug resistant pulsotypes of Acinetobacter baumannii as a potential therapeutic approach.
    Yeganeh O; Shabani M; Pakzad P; Mosaffa N; Hashemi A
    Ann Clin Microbiol Antimicrob; 2022 Jun; 21(1):30. PubMed ID: 35773688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of novel monoclonal antibodies against outer membrane protein A (OmpA) of Acinetobacter baumannii.
    Yeganeh O; Shabani M; Pakzad P; Mosaffa N; Hashemi A
    J Immunol Methods; 2021 Dec; 499():113169. PubMed ID: 34666009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic, Humanized Monoclonal Antibody Exhibits Broad Binding and Protective Efficacy against Acinetobacter baumannii.
    Slarve M; Reyna Z; Burk E; Ruiz-Delgado J; Li R; Yan J; Luna B; Spellberg B
    Antimicrob Agents Chemother; 2023 Mar; 67(3):e0008623. PubMed ID: 36853012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody Dependent Enhancement of
    Wang-Lin SX; Olson R; Beanan JM; MacDonald U; Russo TA; Balthasar JP
    J Pharmacol Exp Ther; 2019 Mar; 368(3):475-489. PubMed ID: 30606761
    [No Abstract]   [Full Text] [Related]  

  • 15. The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.
    Russo TA; Beanan JM; Olson R; MacDonald U; Cox AD; St Michael F; Vinogradov EV; Spellberg B; Luke-Marshall NR; Campagnari AA
    Infect Immun; 2013 Mar; 81(3):915-22. PubMed ID: 23297385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of a Phage-Encoded Wzy Protein in the Polymerization of K127 Units To Form the Capsular Polysaccharide of Acinetobacter baumannii Isolate 36-1454.
    Arbatsky NP; Kasimova AA; Shashkov AS; Shneider MM; Popova AV; Shagin DA; Shelenkov AA; Mikhailova YV; Yanushevich YG; Hall RM; Knirel YA; Kenyon JJ
    Microbiol Spectr; 2022 Jun; 10(3):e0150321. PubMed ID: 35475638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with recombinant DcaP-like protein and AbOmpA revealed protections against sepsis infection of multi-drug resistant Acinetobacter baumannii ST2
    Fereshteh S; Ajdary S; Sepehr A; Bolourchi N; Barzi SM; Haririzadeh Jouriani F; Riazi-Rad F; Shahcheraghi F; Badmasti F
    Microb Pathog; 2023 Jan; 174():105882. PubMed ID: 36403713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Acinetobacter baumannii Capsular Polysaccharide Cleavage by Phage Depolymerases.
    Knirel YA; Shneider MM; Popova AV; Kasimova AA; Senchenkova SN; Shashkov AS; Chizhov AO
    Biochemistry (Mosc); 2020 May; 85(5):567-574. PubMed ID: 32571186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal Antibody Requires Immunomodulation for Efficacy Against Acinetobacter baumannii Infection.
    Nielsen TB; Yan J; Luna BM; Talyansky Y; Slarve M; Bonomo RA; Spellberg B
    J Infect Dis; 2021 Dec; 224(12):2133-2147. PubMed ID: 34036366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Antibodies Mediate Protection Against Acinetobacter baumannii Respiratory Infections.
    Islam A; Actis LA; Wilson TJ
    J Infect Dis; 2023 Aug; 228(3):353-363. PubMed ID: 36951192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.